ResMed Inc.
Justin Leong (Chief Product Officer) reports RMD insider transactions
AI-generated summary
Justin Leong, Chief Product Officer of ResMed Inc., received 10,314 shares as a grant on November 19, 2026. After this transaction, the insider directly held 10,314 shares. The grant represents performance-based restricted stock units earned after meeting performance metrics.
Key facts
- Insider
- Justin Leong · Chief Product Officer
| Date | Transaction | Shares | Price | Value | Held after | Ownership |
|---|---|---|---|---|---|---|
| Nov 19, 2026 | A · grantFootnotes F1 | +10,314 | $0.00 | $0.00 | 10,314 | Direct |
Footnotes
- F1 Represents performance-based restricted stock units granted on November 16, 2023. The shares were earned on November 19, 2026, when the compensation and leadership development committee certified that the performance metrics were met for this portion of the grant.
More RMD filings
- 4
Filed Nov 20, 2026
- 4
Filed Nov 20, 2026
- 4
Filed Nov 20, 2026
- 4
Filed Nov 20, 2026
- 4
Filed Nov 20, 2026
- 4
Filed Nov 20, 2026
Not investment advice. Summaries can contain errors; the SEC filing is the official record.